Adsorbtion of Cytokines Early in Septic Shock: the ACESS Study
NCT02288975 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2018-03-27
Summary
The aim of the study is to investigate the effect of CytoSorb® treatment within the first 48 hours of septic shock on organ dysfunction, microcirculation and on the cytokine storm as monitored by leukocyte activation and inflammatory mediators.
Conditions
- Sepsis
- Septic Shock
Interventions
- DEVICE
-
CytoSorb 300ml device (3804606CE01)
Sponsors & Collaborators
-
Zsolt Molnár, MD, PhD, DEAA
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- Hungary
Study Locations
More Related Trials
-
Efficacy Study of CytoSorb Hemoperfusion Device on IL-6 Removal in ARDS/ALI Patients With Sepsis
NCT00559130 ·Status: COMPLETED ·Phase: NA
-
A RCT to Assess the Performance of CytoSorb for Shock Reversal in Patients With Vasoplegic Septic Shock
NCT04963920 ·Status: SUSPENDED ·Phase: NA
-
Assessing the Effects of CytoSorb Hemoperfusion on the Development on Immunoparalysis
NCT04643639 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Study for the Application of Cytosorb® in Critically Ill Patients
NCT04913298 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Extracorporeal Cytokine Hemoadsorption in Septic Shock in Critically Ill Cirrhotics
NCT03866083 ·Status: UNKNOWN ·Phase: NA
-
Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19
NCT04344080 ·Status: COMPLETED ·Phase: NA
-
Endotoxin Activity Assay and Microcirculation in Severe Sepsis
NCT02452138 ·Status: UNKNOWN
-
Effects of Endotoxin Absorption and Cytokine Removal Hemofilter on Severe Septic Shock
NCT03974386 ·Status: COMPLETED ·Phase: NA
-
Changes in Microvascular Perfusion During Blood Purification With Cytosorb® in Septic Shock
NCT03456180 ·Status: COMPLETED
-
Blood Purification in Patients With Septic Shock
NCT04957316 ·Status: UNKNOWN ·Phase: NA
-
Effect of Citrulline on the Clinical and Biochemical Evolution of Patients With Sepsis.
NCT02370030 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Microcirculation Recruitment Using Albumin 20% and Terlipressin in Septic Patients
NCT05080543 ·Status: UNKNOWN ·Phase: PHASE1
-
Extracorporal Cytokin Removal in Septic Shock: a Prospective, Randomized, Multicenter Clinical Trial
NCT04742764 ·Status: SUSPENDED ·Phase: PHASE3
-
Hemodynamic Impact of Cytosorb and CKRT in Children With Septic Shock
NCT05658588 ·Status: COMPLETED ·Phase: NA
-
Data Analysis of the Cytokine Adsorption Treatment on Coronavirus Disease-19 (COVID-19) Patients With Respiratory Failure
NCT04422626 ·Status: WITHDRAWN
-
A Study to Compare the Efficacy and Safety of 2 Dosing Regimens of IV Infusions of AZD9773 (CytoFab™) With Placebo in Adult Patients With Severe Sepsis and/or Septic Shock
NCT01145560 ·Status: COMPLETED ·Phase: PHASE2
-
ECMOsorb Trial - Impact of a VA-ECMO in Combination With CytoSorb in Critically Ill Patients With Cardiogenic Shock
NCT05027529 ·Status: COMPLETED ·Phase: NA
-
Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?
NCT02903082 ·Status: TERMINATED
-
A STUDY BEFORE/AFTER THE IMPLEMENTATION OF AN ANTI-INFECTIOUS PRESCRIPTION AID
NCT05140213 ·Status: COMPLETED
-
Effects of Renal Replacement Therapy With Hemoadsoption in Patients With Sepsis
NCT04533256 ·Status: COMPLETED
-
SY-005 （Recombinant Human Annexin A5）in Patients With Sepsis
NCT04898322 ·Status: UNKNOWN ·Phase: PHASE2
-
Influence of Cytosorb on Amount of Catecholamine and Mortality in Sepsis
NCT04567199 ·Status: COMPLETED
-
Plasmaexchange in Early Septic Shock
NCT03065751 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study Evaluating the Efficacy and Safety of Colchicine in Adult Patients With Sepsis
NCT07074990 ·Status: COMPLETED ·Phase: NA
-
Glycocalyx and Microcirculation in Sepsis
NCT03960307 ·Status: COMPLETED